Bosnian initiative presses minister on medicine list review amid expanded cancer drug access

The Federation of BiH government expanded access to pembrolizumab and atezolizumab for multiple severe cancers on September 23, but the 'Glasaj za život' initiative is questioning whether the mandate will end without a formal review of the Solidarity Fund's List of Medicines. The expansion is confirmed, but the status of the broader list review remains uncertain. This matters as it affects patient access to costly oncology treatments in a politically sensitive health-policy context.